診断用ラジオアイソトープ市場：ラジオアイソトープ別、用途別、イメージングモダリティ別、適応症別、エンドユーザー別、地域別

診断用ラジオアイソトープ市場は、2025年には67億4,000万米ドルと推定され、2032年には123億2,000万米ドルに達し、2025年から2032年までの年間平均成長率（CAGR）で9%の成長が予測されています。

診断用ラジオアイソトープの世界市場は、慢性疾患の有病率の増加、医療画像技術の進歩、正確な診断手順に対する需要の高まりにより、著しい成長を遂げています。診断用ラジオアイソトープは、様々な疾患や状態を診断するための医療用画像診断に使用される放射性物質です。これらの放射性同位元素は放射線を放出し、画像診断装置で検出することができるため、医療専門家は身体の内部構造を可視化し分析することができます。

市場力学：

世界の診断用ラジオアイソトープ市場の市場力学は、いくつかの要因によって影響を受けています。がん、心血管疾患、神経障害などの慢性疾患の有病率の増加が、診断用ラジオアイソトープの需要を牽引しています。これらの放射性同位元素は、陽電子放射断層撮影法（PET）、単光子放射コンピュータ断層撮影法（SPECT）、ガンマカメラなどの様々な画像診断技術に使用され、これらの疾患を検出・診断します。

しかし、市場の成長を阻害する要因もあります。診断用ラジオアイソトープのコストが高く、その製造と使用に関する規制要件が厳しいことが、市場成長の課題となっています。さらに、入手可能な放射性同位元素が限られていること、一部の同位元素の半減期が短いことから、特定の診断手順における使用が制限される可能性があります。

こうした課題にもかかわらず、市場にはいくつかの成長機会があります。PET/CTやSPECT/CTのようなハイブリッドイメージング技術の採用が増加していることが、診断用ラジオアイソトープの需要を牽引すると予想されます。さらに、新規放射性同位元素や放射性医薬品の開発、イメージング技術の進歩により、市場に新たな機会が生まれると期待されています。

本調査の主な特徴

• 本レポートでは、世界の診断用ラジオアイソトープ市場を詳細に分析し、2024年を基準年とした予測期間（2025-2032年）の市場規模および複合年間成長率（CAGR%）を掲載しています。
• また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案のマトリックスについて説明しています。
• また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
• 企業ハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略などのパラメータに基づいて、世界の診断用ラジオアイソトープ市場の主要企業をプロファイルしています。
• このレポートからの洞察は、マーケティング担当者や企業の経営陣が、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことを可能にするでしょう。
• 世界の診断用ラジオアイソトープ市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。
• 利害関係者は、世界の診断用ラジオアイソトープ市場の分析に使用される様々な戦略マトリックスを通じて意思決定を容易にすることができます。

目次

第1章 調査の目的と前提条件

• 調査目的
• 前提条件
• 略語

第2章 市場の展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー
• Coherent Opportunity Map（COM）

第3章 市場力学、規制、動向分析

• 市場力学
  • 促進要因
• がん、心血管疾患、神経疾患などの慢性疾患の有病率の増加
  • 抑制要因
• 診断用ラジオアイソトープの高コスト
  • 機会
• ハイブリッド画像技術の採用増加
• 影響分析
• 主なハイライト
• 規制シナリオ
• 製品の発売/承認
• PEST分析
• PORTERの分析
• 合併と買収のシナリオ

第4章 世界の診断用ラジオアイソトープ市場 - コロナウイルス（COVID-19）パンデミックの影響

• COVID-19疫学
• 供給側と需要側の分析
• 経済への影響

第5章 世界の診断用ラジオアイソトープ市場、ラジオアイソトープ別、2020年～2032年

• テクネチウム99m
• タリウム201
• ガリウム67
• ヨウ素123
• FDG
• ルビジウム82
• その他

第6章 世界の診断用ラジオアイソトープ市場、用途別、2020年～2032年

• 診断用途
• 治療用途

第7章 世界の診断用ラジオアイソトープ市場、イメージングモダリティ別、2020年～2032年

• SPECT
• PET
• ベータ放射体

第8章 世界の診断用ラジオアイソトープ市場、適応症別、2020年～2032年

• 腫瘍
• 心臓病
• 神経
• 甲状腺
• 整形外科
• 内分泌
• その他

第9章 世界の診断用ラジオアイソトープ市場、エンドユーザー別、2020年～2032年

• 病院
• 専門クリニック
• 診断センター
• 学術研究機関
• その他

第10章 世界の診断用ラジオアイソトープ市場、地域別、2020年～2032年

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • 英国
  • スペイン
  • フランス
  • イタリア
  • ロシア
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • ASEAN
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
  • メキシコ
  • その他ラテンアメリカ
• 中東
  • GCC諸国
  • イスラエル
  • その他中東
• アフリカ
  • 南アフリカ
  • 北アフリカ
  • 中央アフリカ

第11章 競合情勢

• GE Healthcare
• Siemens Healthineers
• Koninklijke Philips N.V.
• Cardinal Health
• Lantheus Holdings, Inc.
• Bayer AG
• Bracco
• Eckert & Ziegler
• Nordion（Canada）Inc.
• NTP Radioisotopes
• Curium
• Jubilant Life Sciences Ltd
• IRE
• Isotopia Molecular Imaging Ltd.
• Mallinckrodt Nuclear Medicine LLC
• Jubilant DraxImage Inc.
• Sumitomo Heavy Industries, Ltd.
• Telix Pharmaceuticals Limited

第12章 セクション

• 調査手法
• 出版社について

Diagnostic Radioisotopes Market is estimated to be valued at USD 6.74 Bn in 2025 and is expected to reach USD 12.32 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9% from 2025 to 2032.

The global market for diagnostic radioisotopes is experiencing significant growth due to the increasing prevalence of chronic diseases, advancements in medical imaging technology, and the rising demand for accurate diagnostic procedures. Diagnostic radioisotopes are radioactive substances that are used in medical imaging to diagnose various diseases and conditions. These isotopes emit radiation that can be detected by imaging devices, allowing healthcare professionals to visualize and analyze the internal structures of the body.

Market Dynamics:

The market dynamics of the global diagnostic radioisotopes market are influenced by several factors. The increasing prevalence of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders is driving the demand for diagnostic radioisotopes. These isotopes are used in various imaging techniques such as positron emission tomography (PET), single-photon emission computed tomography (SPECT), and gamma cameras to detect and diagnose these diseases.

However, there are certain restraints that may hinder the growth of the market. The high cost of diagnostic radioisotopes and the stringent regulatory requirements for their production and use pose challenges for market growth. Additionally, the limited availability of radioisotopes and the short half-life of some isotopes may limit their use in certain diagnostic procedures.

Despite these challenges, the market presents several opportunities for growth. The increasing adoption of hybrid imaging techniques, such as PET/CT and SPECT/CT, is expected to drive the demand for diagnostic radioisotopes. Moreover, the development of novel radioisotopes and radiopharmaceuticals, as well as advancements in imaging technology, are expected to create new opportunities in the market.

Key features of the study:

• This report provides in-depth analysis of the global diagnostic radioisotopes market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global diagnostic radioisotopes market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include GE Healthcare, Siemens Healthineers, Philips Healthcare , Cardinal Health , Lantheus Medical Imaging, Bayer AG, Bracco Imaging, EczacIbasI-Monrol Nuclear Products , Nordion, Advanced Accelerator Applications, NTP Radioisotopes, Curium Pharma, Jubilant Life Sciences Ltd , IRE - IRE ELiT - Instituto de Pesquisas Energeticas e Nucleares, Australian Nuclear Science and Technology Organisation (ANSTO), Eckert & Ziegler Radiopharma GmbH, Isotopia Molecular Imaging Ltd. , Institute of Atomic Energy of Bangladesh , Rosatom State Atomic Energy Corporation, Board of Radiation and Isotope Technology (BRIT)
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global diagnostic radioisotopes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global diagnostic radioisotopes market

Detailed Segmentation:

• Global Diagnostic Radioisotopes Market, By Radioisotope
  • Technetium-99m
  • Thallium-201
  • Gallium-67
  • Iodine-123
  • FDG
  • Rubidium-82
  • Others
• Global Diagnostic Radioisotopes Market, By Application
  • Diagnostic Application
  • Therapeutic Application
• Global Diagnostic Radioisotopes Market, By Imaging Modality
  • SPECT
  • PET
  • Beta Emitters
• Global Diagnostic Radioisotopes Market, By End User
  • Hospitals
  • Diagnostic Centers
  • Research Institutes
  • Others
• Global Diagnostic Radioisotopes Market, By Indication
  • Cardiology
  • Oncology
  • Neurology
  • Others
• Global Diagnostic Radioisotopes Market, By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
• Company Profile:
  • GE Healthcare
  • Siemens Healthineers
  • Philips Healthcare
  • Cardinal Health
  • Lantheus Medical Imaging
  • Bayer AG
  • Bracco Imaging
  • EczacIbasI-Monrol Nuclear Products
  • Nordion
  • Advanced Accelerator Applications
  • NTP Radioisotopes
  • Curium Pharma
  • Jubilant Life Sciences Ltd
  • IRE - IRE ELiT - Instituto de Pesquisas Energeticas e Nucleares
  • Australian Nuclear Science and Technology Organisation (ANSTO)
  • Eckert & Ziegler Radiopharma GmbH
  • Isotopia Molecular Imaging Ltd.
  • Institute of Atomic Energy of Bangladesh
  • Rosatom State Atomic Energy Corporation
  • Board of Radiation and Isotope Technology (BRIT)

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Diagnostic Radioisotopes, By Radioisotope
  • Market Diagnostic Radioisotopes, By Application
  • Market Diagnostic Radioisotopes, By Imaging Modality
  • Market Diagnostic Radioisotopes, By Indication
  • Market Diagnostic Radioisotopes, By End User
  • Market Diagnostic Radioisotopes, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
• Increasing prevalence of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders
  • Restraints
• High cost of diagnostic radioisotopes
  • Opportunities
• Increasing adoption of hybrid imaging techniques
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Diagnostic Radioisotopes Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Diagnostic Radioisotopes Market, By Radioisotope, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Technetium-99m
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Thallium-201
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Gallium-67
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Iodine-123
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• FDG
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Rubidium-82
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Global Diagnostic Radioisotopes Market, By Application, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021- 2032
  • Segment Trends
• Diagnostic Application
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Therapeutic Application
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

7. Global Diagnostic Radioisotopes Market, By Imaging Modality, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021- 2032
  • Segment Trends
• SPECT
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• PET
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Beta Emitters
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

8. Global Diagnostic Radioisotopes Market, By Indication, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021- 2032
  • Segment Trends
• Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Cardiology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Neurology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Thyroid
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Orthopedic
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Endocrinology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

9. Global Diagnostic Radioisotopes Market, By End User, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021- 2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Specialty Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Diagnostic Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Academic & Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

10. Global Diagnostic Radioisotopes Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021-2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,( US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)
    • South Africa
    • North Africa
    • Central Africa

11. Competitive Landscape

• GE Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Siemens Healthineers
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Koninklijke Philips N.V.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Cardinal Health
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Lantheus Holdings, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Bayer AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Bracco
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Eckert & Ziegler
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Nordion (Canada) Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• NTP Radioisotopes
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Curium
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Jubilant Life Sciences Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• IRE
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Isotopia Molecular Imaging Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Mallinckrodt Nuclear Medicine LLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Jubilant DraxImage Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Sumitomo Heavy Industries, Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Telix Pharmaceuticals Limited
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

12. Section

• Research Methodology
• About us